-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ijmp2Xd85bQfozl5scoQfOaUnyc2piLIJjcAZJUe0mnWa23Batumkm7pvdW5775z 6LcGvCbwbYbDOICXMnuvfw== 0001209191-09-051379.txt : 20091106 0001209191-09-051379.hdr.sgml : 20091106 20091106132922 ACCESSION NUMBER: 0001209191-09-051379 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091104 FILED AS OF DATE: 20091106 DATE AS OF CHANGE: 20091106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 091163846 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-11-04 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001206369 KLEIN JOSEPH III C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451 1 0 0 0 Common Stock 2009-11-04 4 M 0 2500 6.894 A 19483 D Common Stock 2009-11-04 4 M 0 1500 6.894 A 20983 D Common Stock 2009-11-04 4 M 0 667 6.894 A 21650 D Common Stock 2009-11-04 4 M 0 1000 6.894 A 22650 D Common Stock 2009-11-04 4 M 0 4583 6.894 A 27233 D Common Stock 2009-11-04 4 M 0 13750 6.894 A 40983 D Common Stock 2009-11-04 4 S 0 900 8.29 D 40083 D Common Stock 2009-11-04 4 S 0 700 8.2925 D 39383 D Common Stock 2009-11-04 4 S 0 400 8.295 D 38983 D Common Stock 2009-11-04 4 S 0 1800 8.30 D 37183 D Common Stock 2009-11-04 4 S 0 200 8.3025 D 36983 D Common Stock 2009-11-04 4 S 0 400 8.31 D 36583 D Common Stock 2009-11-04 4 S 0 6200 8.32 D 30383 D Common Stock 2009-11-04 4 S 0 100 8.3225 D 30283 D Common Stock 2009-11-04 4 S 0 3300 8.33 D 26983 D Common Stock 2009-11-04 4 S 0 9300 8.34 D 17683 D Common Stock 2009-11-04 4 S 0 700 8.3425 D 16983 D Common Stock 1 I By Trust Common Stock 10 I By Wife Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 2500 0.00 D 2009-05-28 2015-05-28 Common Stock 2500 21500 D Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 1500 0.00 D 2009-05-28 2015-05-28 Common Stock 1500 20000 D Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 667 0.00 D 2009-05-28 2015-05-28 Common Stock 667 19333 D Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 1000 0.00 D 2009-05-28 2015-05-28 Common Stock 1000 18333 D Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 4583 0.00 D 2009-05-28 2015-05-28 Common Stock 4583 13750 D Stock Option (Right to Buy) 6.894 2009-11-04 4 M 0 13750 0.00 D 2009-05-28 2015-05-28 Common Stock 13750 0 D The exercise price adjusted from $9.79 per share to $6.894 per share in connection with the spin-off of Facet Biotech Corporation. /s/ Christopher Stone as Attorney-in-fact for Robert Klein III 2009-11-06 -----END PRIVACY-ENHANCED MESSAGE-----